ONI
PrivateLast Round
Series B
Jan 20, 2022
Est. Valuation
$100M
Total Funding Raised
$105.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ONI operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series B round in January 2022.
ONI is a biotechnology company that develops single-molecule super-resolution microscopes to enhance biological research by allowing researchers to visualize and analyze molecules and structures within living cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONI Comparables
Compare ONI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abberior Instruments | 82% | |
| Abbelight | 80% | |
| CSR Biotech | 78% |
For institutional investors. Book with your work email.
ONI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 20, 2022 | ||||
| Grant | Jan 1, 2021 | ||||
| Series A | Jul 1, 2018 | ||||
| Seed | Apr 1, 2017 | ||||
| Seed | May 10, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ONI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| IP Group | Series A |
| Oxford Science Enterprises | Series B, Seed |
| ARTIS Ventures | Series B |
| Axon Ventures | Series B |
| ARCH Venture Partners | Series B |
| Vertical Venture Partners | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 162% MoM, reaching 46.6K.
- Feb 24, 2026
Launched LNP PREP for sample-to-answer automation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 16, 2026
ONI is selected as one of the 2026 Health & Life Sciences Trailblazers through the Trailblazers Programme, delivered in partnership with WIRED and HSBC UK, in recognition of its work to transform how researchers understand biology at the nanoscale, with the recognition announced in the United States and United Kingdom on Sep 16th '26.
- recognized_asSep 16, 2026
ONI is named a 2026 Health Trailblazer and joins a select group of innovative companies recognized through the Trailblazers Programme, delivered in partnership with WIRED and HSBC UK, on Sep 16th '26.
For institutional investors. Book with your work email.
ONI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ONI's valuation, stock price, and market status.
Is ONI a public or private company?
ONI is a private company.
What is the current stock price of ONI?
ONI is a private company, so its shares have no public market price. Caplight tracks ONI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ONI worth (valuation)?
ONI's valuation is estimated at $100.0M based on funding round data.
Can I buy ONI stock?
ONI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ONI's last funding round?
ONI's most recent funding round was Series B on January 20, 2022.
Who are the main investors in ONI?
Key investors in ONI include Oxford Science Enterprises, ARCH Venture Partners, Casdin Capital, European Union, Oxford Technology.
Will ONI IPO soon?
No public IPO plans have been announced for ONI.
How can I track ONI secondary market activity?
Caplight tracks bids, offers, and trades in ONI's shares on secondary markets.